Below are the most recent publications written about "Administration, Topical" by people in Profiles.
-
Shingade K, Sutar Y, Annaji M, Kulkarni M, Date AA. Borneol-caprylic acid deep eutectic solvent (DES) based microemulsion gel for improved topical delivery of ivermectin. Int J Pharm. 2026 May 05; 696:126819.
-
Mallick S, Sharma P, Yadavalli T, Koganti R, Singh SK, Yoshimura K, Kapoor D, Sutar Y, Adams JS, Annaji M, Shukla D, Date AA. Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection. Int J Pharm. 2026 Apr 25; 695:126672.
-
Badruddoza AZM, Zahid MI, Walsh T, Shah J, Gates D, Yeoh T, Nurunnabi M. Topical drug delivery by Sepineo P600 emulgel: Relationship between rheology, physical stability, and formulation performance. Int J Pharm. 2024 Jun 10; 658:124210.
-
Kulkarni M, Potdar S, Date AA, Marfatiya A. In Vitro Release Testing of Acyclovir Topical Formulations Using Immersion Cells. Assay Drug Dev Technol. 2021 Feb-Mar; 19(2):75-84.
-
Kim YC, Shin MD, Hackett SF, Hsueh HT, Lima E Silva R, Date A, Han H, Kim BJ, Xiao A, Kim Y, Ogunnaike L, Anders NM, Hemingway A, He P, Jun AS, McDonnell PJ, Eberhart C, Pitha I, Zack DJ, Campochiaro PA, Hanes J, Ensign LM. Gelling hypotonic polymer solution for extended topical drug delivery to the eye. Nat Biomed Eng. 2020 11; 4(11):1053-1062.
-
Coppola-Fasick G, Nazario S. Recurrent otitis externa owing to allergic contact dermatitis to topical medications. Ann Allergy Asthma Immunol. 2020 11; 125(5):616-617.
-
Chen JY, Le A, Caprioli J, Giaconi JA, Nouri-Mahdavi K, Law SK, Bonelli L, Coleman AL, Demer JL. Orbital Fat Volume After Treatment with Topical Prostaglandin Agonists. Invest Ophthalmol Vis Sci. 2020 05 11; 61(5):46.
-
Watts-Oquendo ET, Coppola-Fasick G, Arroyo-Flores E, Soto-Salgado M, Nazario S. Effect of topical pramoxine hydrochloride on discomfort, wheal and flare associated with epicutaneous allergy test. Ann Allergy Asthma Immunol. 2019 06; 122(6):652-653.
-
Wren C, Bell E, Eiland LS. Ozenoxacin: A Novel Topical Quinolone for Impetigo. Ann Pharmacother. 2018 12; 52(12):1233-1237.
-
Akyol O, Sherchan P, Yilmaz G, Reis C, Ho WM, Wang Y, Huang L, Solaroglu I, Zhang JH. Neurotrophin-3 provides neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model. Exp Neurol. 2018 09; 307:82-89.